Rank | Gene Set | Z-score |
---|---|---|
1 | exogenous drug catabolic process (GO:0042738) | 8.46878623 |
2 | L-phenylalanine catabolic process (GO:0006559) | 7.61402865 |
3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.61402865 |
4 | epoxygenase P450 pathway (GO:0019373) | 7.39324842 |
5 | L-phenylalanine metabolic process (GO:0006558) | 7.23736007 |
6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.23736007 |
7 | omega-hydroxylase P450 pathway (GO:0097267) | 7.13005578 |
8 | aromatic amino acid family catabolic process (GO:0009074) | 6.78627210 |
9 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.24072847 |
10 | tryptophan catabolic process (GO:0006569) | 6.09239875 |
11 | indole-containing compound catabolic process (GO:0042436) | 6.09239875 |
12 | indolalkylamine catabolic process (GO:0046218) | 6.09239875 |
13 | oxidative demethylation (GO:0070989) | 5.93371899 |
14 | kynurenine metabolic process (GO:0070189) | 5.88269714 |
15 | tryptophan metabolic process (GO:0006568) | 5.78207304 |
16 | bile acid biosynthetic process (GO:0006699) | 5.77833413 |
17 | drug metabolic process (GO:0017144) | 5.69681077 |
18 | negative regulation of fibrinolysis (GO:0051918) | 5.69502201 |
19 | uronic acid metabolic process (GO:0006063) | 5.67771081 |
20 | high-density lipoprotein particle remodeling (GO:0034375) | 5.60760860 |
21 | glyoxylate metabolic process (GO:0046487) | 5.58537723 |
22 | regulation of fibrinolysis (GO:0051917) | 5.58311680 |
23 | regulation of protein activation cascade (GO:2000257) | 5.55300822 |
24 | urea metabolic process (GO:0019627) | 5.50673109 |
25 | urea cycle (GO:0000050) | 5.50673109 |
26 | complement activation, alternative pathway (GO:0006957) | 5.49563668 |
27 | protein carboxylation (GO:0018214) | 5.46272978 |
28 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.46272978 |
29 | alpha-linolenic acid metabolic process (GO:0036109) | 5.23701214 |
30 | regulation of complement activation (GO:0030449) | 5.12141748 |
31 | phenylpropanoid metabolic process (GO:0009698) | 5.10918532 |
32 | nitrogen cycle metabolic process (GO:0071941) | 5.06488158 |
33 | cysteine metabolic process (GO:0006534) | 5.04332644 |
34 | sulfur amino acid catabolic process (GO:0000098) | 4.99409302 |
35 | bile acid metabolic process (GO:0008206) | 4.97294774 |
36 | aromatic amino acid family metabolic process (GO:0009072) | 4.94490999 |
37 | reverse cholesterol transport (GO:0043691) | 4.93713463 |
38 | regulation of cholesterol esterification (GO:0010872) | 4.93248043 |
39 | serine family amino acid catabolic process (GO:0009071) | 4.84589145 |
40 | tyrosine metabolic process (GO:0006570) | 4.81830613 |
41 | protein-lipid complex remodeling (GO:0034368) | 4.81525660 |
42 | macromolecular complex remodeling (GO:0034367) | 4.81525660 |
43 | plasma lipoprotein particle remodeling (GO:0034369) | 4.81525660 |
44 | regulation of triglyceride catabolic process (GO:0010896) | 4.75550331 |
45 | phospholipid efflux (GO:0033700) | 4.70067135 |
46 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.68825504 |
47 | triglyceride homeostasis (GO:0070328) | 4.63504888 |
48 | acylglycerol homeostasis (GO:0055090) | 4.63504888 |
49 | homocysteine metabolic process (GO:0050667) | 4.54478806 |
50 | S-adenosylmethionine metabolic process (GO:0046500) | 4.51917976 |
51 | alkaloid metabolic process (GO:0009820) | 4.49466489 |
52 | alpha-amino acid catabolic process (GO:1901606) | 4.48776343 |
53 | indolalkylamine metabolic process (GO:0006586) | 4.42350288 |
54 | coenzyme catabolic process (GO:0009109) | 4.42329922 |
55 | plasma lipoprotein particle clearance (GO:0034381) | 4.40312091 |
56 | negative regulation of cholesterol transport (GO:0032375) | 4.39987808 |
57 | negative regulation of sterol transport (GO:0032372) | 4.39987808 |
58 | negative regulation of complement activation (GO:0045916) | 4.34648689 |
59 | bile acid and bile salt transport (GO:0015721) | 4.32606863 |
60 | amino-acid betaine metabolic process (GO:0006577) | 4.31659406 |
61 | cholesterol efflux (GO:0033344) | 4.31655392 |
62 | lysine catabolic process (GO:0006554) | 4.29316645 |
63 | lysine metabolic process (GO:0006553) | 4.29316645 |
64 | cellular ketone body metabolic process (GO:0046950) | 4.25791500 |
65 | regulation of plasminogen activation (GO:0010755) | 4.25627960 |
66 | amine catabolic process (GO:0009310) | 4.25180212 |
67 | cellular biogenic amine catabolic process (GO:0042402) | 4.25180212 |
68 | regulation of humoral immune response (GO:0002920) | 4.20280127 |
69 | imidazole-containing compound metabolic process (GO:0052803) | 4.16048023 |
70 | fibrinolysis (GO:0042730) | 4.12877102 |
71 | cellular amino acid catabolic process (GO:0009063) | 4.10562771 |
72 | ethanol metabolic process (GO:0006067) | 4.09282437 |
73 | glutamate metabolic process (GO:0006536) | 4.08101052 |
74 | plasma lipoprotein particle assembly (GO:0034377) | 4.06637006 |
75 | negative regulation of hemostasis (GO:1900047) | 4.06574203 |
76 | negative regulation of blood coagulation (GO:0030195) | 4.06574203 |
77 | glycine metabolic process (GO:0006544) | 4.04800651 |
78 | benzene-containing compound metabolic process (GO:0042537) | 4.04143874 |
79 | flavonoid metabolic process (GO:0009812) | 4.03520119 |
80 | blood coagulation, intrinsic pathway (GO:0007597) | 3.99088488 |
81 | cellular glucuronidation (GO:0052695) | 3.97013729 |
82 | acute-phase response (GO:0006953) | 3.94007376 |
83 | cellular modified amino acid catabolic process (GO:0042219) | 3.93585945 |
84 | serine family amino acid metabolic process (GO:0009069) | 3.88383148 |
85 | low-density lipoprotein particle remodeling (GO:0034374) | 3.87990213 |
86 | negative regulation of protein activation cascade (GO:2000258) | 3.86640624 |
87 | opsonization (GO:0008228) | 3.86034183 |
88 | complement activation, classical pathway (GO:0006958) | 3.85438098 |
89 | arginine metabolic process (GO:0006525) | 3.85073688 |
90 | negative regulation of lipase activity (GO:0060192) | 3.84610933 |
91 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.84128661 |
92 | protein activation cascade (GO:0072376) | 3.83756326 |
93 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.82668095 |
94 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.82668095 |
95 | drug catabolic process (GO:0042737) | 3.82262709 |
96 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.81120168 |
97 | cofactor catabolic process (GO:0051187) | 3.80691805 |
98 | heme transport (GO:0015886) | 3.78949406 |
99 | aldehyde catabolic process (GO:0046185) | 3.77828289 |
100 | complement activation (GO:0006956) | 3.77019308 |
101 | cytolysis (GO:0019835) | 3.74895385 |
102 | negative regulation of wound healing (GO:0061045) | 3.72858511 |
103 | regulation of bile acid biosynthetic process (GO:0070857) | 3.71761257 |
104 | negative regulation of coagulation (GO:0050819) | 3.71567691 |
105 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.71117500 |
106 | cholesterol homeostasis (GO:0042632) | 3.68104876 |
107 | ketone body metabolic process (GO:1902224) | 3.68072219 |
108 | phospholipid homeostasis (GO:0055091) | 3.67667722 |
109 | plasma lipoprotein particle organization (GO:0071827) | 3.67350880 |
110 | ethanol oxidation (GO:0006069) | 3.66408907 |
111 | serine family amino acid biosynthetic process (GO:0009070) | 3.65721192 |
112 | intestinal cholesterol absorption (GO:0030299) | 3.63420749 |
113 | regulation of cholesterol homeostasis (GO:2000188) | 3.63028462 |
114 | positive regulation of lipid catabolic process (GO:0050996) | 3.62819872 |
115 | sterol homeostasis (GO:0055092) | 3.62222982 |
116 | protein-lipid complex assembly (GO:0065005) | 3.60224224 |
117 | carboxylic acid catabolic process (GO:0046395) | 3.59427874 |
118 | organic acid catabolic process (GO:0016054) | 3.59427874 |
119 | short-chain fatty acid metabolic process (GO:0046459) | 3.54892258 |
120 | glucuronate metabolic process (GO:0019585) | 3.54168880 |
121 | L-methionine salvage (GO:0071267) | 3.51936086 |
122 | L-methionine biosynthetic process (GO:0071265) | 3.51936086 |
123 | amino acid salvage (GO:0043102) | 3.51936086 |
124 | xenobiotic metabolic process (GO:0006805) | 3.45670329 |
125 | hormone catabolic process (GO:0042447) | 3.43001148 |
126 | positive regulation of blood coagulation (GO:0030194) | 3.39070468 |
127 | positive regulation of hemostasis (GO:1900048) | 3.39070468 |
128 | steroid catabolic process (GO:0006706) | 3.36376457 |
129 | xenobiotic catabolic process (GO:0042178) | 3.34817045 |
130 | drug transmembrane transport (GO:0006855) | 3.34674799 |
131 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.34421005 |
132 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.34421005 |
Rank | Gene Set | Z-score |
---|---|---|
1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.06299543 |
2 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.92654073 |
3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.83579022 |
4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.28929328 |
5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.21659665 |
6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.12951841 |
7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.22110642 |
8 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.04001468 |
9 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.99757602 |
10 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.69719759 |
11 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.68593962 |
12 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.30427711 |
13 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.21960692 |
14 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.08289205 |
15 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.03379267 |
16 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.5770941 |
17 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.93102170 |
18 | VDR_22108803_ChIP-Seq_LS180_Human | 1.87939150 |
19 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.86969730 |
20 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.80255992 |
21 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.75821602 |
22 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.71590979 |
23 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.71450087 |
24 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.64728213 |
25 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.64338964 |
26 | GATA1_22025678_ChIP-Seq_K562_Human | 1.58968863 |
27 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.53485377 |
28 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.53301113 |
29 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.47419560 |
30 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.42797282 |
31 | P300_19829295_ChIP-Seq_ESCs_Human | 1.39266397 |
32 | STAT3_23295773_ChIP-Seq_U87_Human | 1.38563445 |
33 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.36453427 |
34 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.31972538 |
35 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.31775085 |
36 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.31452971 |
37 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.31452971 |
38 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.26263461 |
39 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.26263461 |
40 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.24500588 |
41 | TCF4_23295773_ChIP-Seq_U87_Human | 1.24311836 |
42 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.23974429 |
43 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.23493836 |
44 | FUS_26573619_Chip-Seq_HEK293_Human | 1.22182670 |
45 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.21173197 |
46 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.21035377 |
47 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.18736877 |
48 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.17627042 |
49 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.17347357 |
50 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.16990314 |
51 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.16484130 |
52 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.15996160 |
53 | AR_25329375_ChIP-Seq_VCAP_Human | 1.14457455 |
54 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.13333545 |
55 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.11630734 |
56 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.11426697 |
57 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.11426697 |
58 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.11413090 |
59 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.10107809 |
60 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.09821327 |
61 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.09808394 |
62 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.08388563 |
63 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.08134203 |
64 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.08127125 |
65 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.07720276 |
66 | PHF8_20622853_ChIP-Seq_HELA_Human | 1.07583915 |
67 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.06750296 |
68 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.06705300 |
69 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.06285926 |
70 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.05881480 |
71 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.05788250 |
72 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.05266763 |
73 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.04464216 |
74 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.01492331 |
75 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 1.01161037 |
76 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.01144095 |
77 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.00394032 |
78 | NFYA_21822215_ChIP-Seq_K562_Human | 1.00063759 |
79 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.98927775 |
80 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.98739615 |
81 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.98334575 |
82 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.98107982 |
83 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.97405686 |
84 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.96565002 |
85 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 0.94634958 |
86 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.94337147 |
87 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.90511786 |
88 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.89732903 |
89 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.88430636 |
90 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.80478151 |
91 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.78663137 |
92 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.78551531 |
93 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.77652909 |
94 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.76973697 |
95 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.76138305 |
96 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.74529606 |
97 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.72813572 |
98 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.72813572 |
99 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.72795895 |
100 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.69283181 |
101 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.69039245 |
102 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.67843585 |
103 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.65928446 |
104 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.65248739 |
105 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.64967233 |
106 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.64914197 |
107 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.64814426 |
108 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.64167359 |
109 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.63961681 |
110 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.61064421 |
111 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.60686803 |
112 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.60559006 |
113 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.60343116 |
114 | * AR_20517297_ChIP-Seq_VCAP_Human | 0.58349844 |
115 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.57777995 |
116 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.56962749 |
117 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.56869252 |
118 | CBP_21632823_ChIP-Seq_H3396_Human | 0.55796643 |
119 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.55699973 |
120 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.55359397 |
121 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.53146278 |
122 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.51976936 |
123 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.51853397 |
124 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.51772107 |
125 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.51649275 |
126 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.51113549 |
127 | * MYC_19915707_ChIP-ChIP_AK7_Human | 0.50649969 |
128 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.50524532 |
129 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.50248782 |
130 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.49855859 |
131 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.49715766 |
132 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.49537062 |
133 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.48882941 |
134 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.48621280 |
135 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.48487115 |
136 | * NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.47183770 |
137 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.47126774 |
138 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.46847995 |
139 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.46532286 |
140 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.46415737 |
141 | GATA1_19941826_ChIP-Seq_K562_Human | 0.44600316 |
142 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.44292554 |
143 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.43955033 |
144 | NCOR_22424771_ChIP-Seq_293T_Human | 0.43497883 |
145 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.43353684 |
146 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.43270624 |
147 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.42572644 |
148 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.42446687 |
149 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.42154159 |
150 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.41965328 |
151 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.41735137 |
152 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.41477865 |
153 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.40911121 |
154 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.40174385 |
155 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.40158383 |
156 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.39009949 |
157 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.38992438 |
158 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.38166746 |
159 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.37494601 |
160 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.37058048 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 8.26409378 |
2 | MP0005360_urolithiasis | 7.32410692 |
3 | MP0005085_abnormal_gallbladder_physiolo | 6.38532972 |
4 | MP0005365_abnormal_bile_salt | 6.28520653 |
5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.91714651 |
6 | MP0003806_abnormal_nucleotide_metabolis | 3.99645588 |
7 | MP0003252_abnormal_bile_duct | 3.92080176 |
8 | MP0010329_abnormal_lipoprotein_level | 3.53805477 |
9 | MP0003195_calcinosis | 3.24391323 |
10 | MP0009840_abnormal_foam_cell | 3.20163008 |
11 | MP0005083_abnormal_biliary_tract | 3.17041574 |
12 | MP0005332_abnormal_amino_acid | 2.71500654 |
13 | MP0001666_abnormal_nutrient_absorption | 2.66550621 |
14 | MP0003191_abnormal_cellular_cholesterol | 2.43054205 |
15 | MP0000609_abnormal_liver_physiology | 2.14282021 |
16 | MP0002118_abnormal_lipid_homeostasis | 2.13208101 |
17 | MP0003868_abnormal_feces_composition | 2.13145310 |
18 | MP0002138_abnormal_hepatobiliary_system | 2.13079580 |
19 | MP0004019_abnormal_vitamin_homeostasis | 2.12730869 |
20 | MP0005319_abnormal_enzyme/_coenzyme | 1.71859141 |
21 | MP0001764_abnormal_homeostasis | 1.63295806 |
22 | MP0009697_abnormal_copulation | 1.58408842 |
23 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.46813195 |
24 | MP0005451_abnormal_body_composition | 1.36199134 |
25 | MP0003011_delayed_dark_adaptation | 1.32911588 |
26 | MP0009643_abnormal_urine_homeostasis | 1.31510117 |
27 | MP0003656_abnormal_erythrocyte_physiolo | 1.11671750 |
28 | MP0005647_abnormal_sex_gland | 1.10617958 |
29 | MP0000598_abnormal_liver_morphology | 1.10535530 |
30 | MP0005551_abnormal_eye_electrophysiolog | 1.09277159 |
31 | MP0003186_abnormal_redox_activity | 1.08755704 |
32 | MP0005636_abnormal_mineral_homeostasis | 1.07674504 |
33 | MP0005187_abnormal_penis_morphology | 1.07484167 |
34 | MP0000604_amyloidosis | 1.06317606 |
35 | MP0005220_abnormal_exocrine_pancreas | 1.03332610 |
36 | MP0002254_reproductive_system_inflammat | 1.00290067 |
37 | MP0002876_abnormal_thyroid_physiology | 0.99018680 |
38 | MP0009764_decreased_sensitivity_to | 0.98521087 |
39 | MP0002078_abnormal_glucose_homeostasis | 0.98053263 |
40 | MP0005084_abnormal_gallbladder_morpholo | 0.96180685 |
41 | MP0002638_abnormal_pupillary_reflex | 0.95615510 |
42 | * MP0009763_increased_sensitivity_to | 0.94772234 |
43 | MP0010368_abnormal_lymphatic_system | 0.94223242 |
44 | MP0005646_abnormal_pituitary_gland | 0.93477750 |
45 | MP0005408_hypopigmentation | 0.91662685 |
46 | * MP0009642_abnormal_blood_homeostasis | 0.91399324 |
47 | MP0010386_abnormal_urinary_bladder | 0.91246412 |
48 | MP0005670_abnormal_white_adipose | 0.89817949 |
49 | MP0008469_abnormal_protein_level | 0.88013437 |
50 | MP0002909_abnormal_adrenal_gland | 0.87607175 |
51 | MP0005645_abnormal_hypothalamus_physiol | 0.85049825 |
52 | MP0001661_extended_life_span | 0.84566426 |
53 | MP0003705_abnormal_hypodermis_morpholog | 0.81527214 |
54 | MP0009765_abnormal_xenobiotic_induced | 0.78413538 |
55 | MP0004142_abnormal_muscle_tone | 0.77090534 |
56 | MP0005535_abnormal_body_temperature | 0.77052429 |
57 | MP0005376_homeostasis/metabolism_phenot | 0.74789223 |
58 | MP0006036_abnormal_mitochondrial_physio | 0.73312765 |
59 | MP0002132_abnormal_respiratory_system | 0.72798879 |
60 | MP0000639_abnormal_adrenal_gland | 0.72182369 |
61 | MP0005334_abnormal_fat_pad | 0.71945630 |
62 | MP0002971_abnormal_brown_adipose | 0.71866607 |
63 | MP0001501_abnormal_sleep_pattern | 0.70818276 |
64 | MP0009046_muscle_twitch | 0.70297296 |
65 | MP0003690_abnormal_glial_cell | 0.68990733 |
66 | MP0001756_abnormal_urination | 0.66770993 |
67 | MP0002837_dystrophic_cardiac_calcinosis | 0.65059880 |
68 | MP0003879_abnormal_hair_cell | 0.64963196 |
69 | MP0005448_abnormal_energy_balance | 0.62102469 |
70 | MP0001944_abnormal_pancreas_morphology | 0.61128048 |
71 | MP0009745_abnormal_behavioral_response | 0.60308769 |
72 | MP0002928_abnormal_bile_duct | 0.58503697 |
73 | MP0003329_amyloid_beta_deposits | 0.58076351 |
74 | MP0000569_abnormal_digit_pigmentation | 0.57644743 |
75 | MP0001984_abnormal_olfaction | 0.57146038 |
76 | MP0001986_abnormal_taste_sensitivity | 0.57047924 |
77 | MP0004130_abnormal_muscle_cell | 0.56129021 |
78 | MP0005266_abnormal_metabolism | 0.55540671 |
79 | MP0008877_abnormal_DNA_methylation | 0.55517938 |
80 | MP0006292_abnormal_olfactory_placode | 0.55513783 |
81 | MP0005167_abnormal_blood-brain_barrier | 0.55222075 |
82 | MP0003953_abnormal_hormone_level | 0.55121535 |
83 | MP0003633_abnormal_nervous_system | 0.52969048 |
84 | MP0003122_maternal_imprinting | 0.52827939 |
85 | MP0002282_abnormal_trachea_morphology | 0.52625305 |
86 | MP0002090_abnormal_vision | 0.52061018 |
87 | MP0005464_abnormal_platelet_physiology | 0.51892615 |
88 | MP0005253_abnormal_eye_physiology | 0.51348041 |
89 | MP0000579_abnormal_nail_morphology | 0.50557088 |
90 | MP0005379_endocrine/exocrine_gland_phen | 0.50323034 |
91 | MP0005395_other_phenotype | 0.49671052 |
92 | MP0006276_abnormal_autonomic_nervous | 0.49278309 |
93 | MP0004043_abnormal_pH_regulation | 0.48982888 |
94 | MP0004381_abnormal_hair_follicle | 0.47835505 |
95 | MP0001324_abnormal_eye_pigmentation | 0.47249829 |
96 | MP0003724_increased_susceptibility_to | 0.46776332 |
97 | MP0003638_abnormal_response/metabolism_ | 0.46166962 |
98 | MP0009053_abnormal_anal_canal | 0.45807580 |
99 | MP0003646_muscle_fatigue | 0.45565165 |
100 | MP0002693_abnormal_pancreas_physiology | 0.44478386 |
101 | MP0002102_abnormal_ear_morphology | 0.43636643 |
102 | MP0002136_abnormal_kidney_physiology | 0.43259800 |
103 | MP0002938_white_spotting | 0.42660434 |
104 | MP0002822_catalepsy | 0.42120343 |
105 | MP0005248_abnormal_Harderian_gland | 0.41922976 |
106 | MP0006072_abnormal_retinal_apoptosis | 0.41170151 |
107 | MP0006035_abnormal_mitochondrial_morpho | 0.41136719 |
108 | MP0004924_abnormal_behavior | 0.41098760 |
109 | MP0005386_behavior/neurological_phenoty | 0.41098760 |
110 | MP0003631_nervous_system_phenotype | 0.40409364 |
111 | MP0003632_abnormal_nervous_system | 0.40279427 |
112 | MP0008874_decreased_physiological_sensi | 0.39955857 |
113 | MP0000371_diluted_coat_color | 0.39579585 |
114 | MP0004782_abnormal_surfactant_physiolog | 0.39228059 |
115 | MP0003718_maternal_effect | 0.38572110 |
116 | MP0004264_abnormal_extraembryonic_tissu | 0.38015368 |
117 | MP0000230_abnormal_systemic_arterial | 0.37746323 |
118 | MP0009384_cardiac_valve_regurgitation | 0.36340572 |
119 | MP0008873_increased_physiological_sensi | 0.35991216 |
120 | MP0009672_abnormal_birth_weight | 0.34737993 |
121 | MP0002168_other_aberrant_phenotype | 0.33721442 |
122 | MP0000427_abnormal_hair_cycle | 0.33165273 |
123 | MP0005666_abnormal_adipose_tissue | 0.32763869 |
124 | MP0003959_abnormal_lean_body | 0.31925650 |
125 | MP0001765_abnormal_ion_homeostasis | 0.31860091 |
126 | MP0003436_decreased_susceptibility_to | 0.31524021 |
127 | MP0003075_altered_response_to | 0.29944360 |
128 | MP0001881_abnormal_mammary_gland | 0.29469274 |
129 | MP0002970_abnormal_white_adipose | 0.29073370 |
130 | MP0005166_decreased_susceptibility_to | 0.27445636 |
131 | MP0000249_abnormal_blood_vessel | 0.25802334 |
132 | MP0009780_abnormal_chondrocyte_physiolo | 0.25451861 |
133 | MP0001243_abnormal_dermal_layer | 0.25344884 |
134 | MP0009115_abnormal_fat_cell | 0.24692738 |
135 | MP0008872_abnormal_physiological_respon | 0.24606073 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.47475951 |
2 | Deep venous thrombosis (HP:0002625) | 7.26659865 |
3 | Intrahepatic cholestasis (HP:0001406) | 7.24826640 |
4 | Prolonged partial thromboplastin time (HP:0003645) | 6.91606416 |
5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.54710054 |
6 | Hypobetalipoproteinemia (HP:0003563) | 6.13903644 |
7 | Xanthomatosis (HP:0000991) | 6.13293503 |
8 | Complement deficiency (HP:0004431) | 5.60441456 |
9 | Hyperlipoproteinemia (HP:0010980) | 5.46328504 |
10 | Joint hemorrhage (HP:0005261) | 5.04236778 |
11 | Abnormality of the common coagulation pathway (HP:0010990) | 4.96917182 |
12 | Hypolipoproteinemia (HP:0010981) | 4.65576846 |
13 | Epidermoid cyst (HP:0200040) | 4.44695402 |
14 | Hypoglycemic coma (HP:0001325) | 4.39505191 |
15 | Ketosis (HP:0001946) | 4.31239073 |
16 | Hyperammonemia (HP:0001987) | 4.30805843 |
17 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.26457668 |
18 | Hyperglycinemia (HP:0002154) | 4.18099036 |
19 | Fat malabsorption (HP:0002630) | 4.17589880 |
20 | Hypoalphalipoproteinemia (HP:0003233) | 4.13512498 |
21 | Abnormality of the intrinsic pathway (HP:0010989) | 4.12317826 |
22 | Conjugated hyperbilirubinemia (HP:0002908) | 4.10769673 |
23 | Abnormality of methionine metabolism (HP:0010901) | 4.10217712 |
24 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.06690146 |
25 | Abnormality of complement system (HP:0005339) | 4.03075115 |
26 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.95747429 |
27 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.94652843 |
28 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.66747674 |
29 | Abnormality of glycine metabolism (HP:0010895) | 3.63776184 |
30 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.63776184 |
31 | Hyperglycinuria (HP:0003108) | 3.62829818 |
32 | Spontaneous abortion (HP:0005268) | 3.55242749 |
33 | Hypercholesterolemia (HP:0003124) | 3.43884008 |
34 | Ketoacidosis (HP:0001993) | 3.34177043 |
35 | Hyperbilirubinemia (HP:0002904) | 3.31522665 |
36 | Hypoglycemic seizures (HP:0002173) | 3.30338829 |
37 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.22843865 |
38 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.11978621 |
39 | Fair hair (HP:0002286) | 3.10454048 |
40 | Nephritis (HP:0000123) | 3.08981988 |
41 | Steatorrhea (HP:0002570) | 3.07646436 |
42 | Hypochromic microcytic anemia (HP:0004840) | 2.98893168 |
43 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.98278046 |
44 | Abnormality of nucleobase metabolism (HP:0010932) | 2.95700214 |
45 | Skin nodule (HP:0200036) | 2.88080515 |
46 | Abnormality of serum amino acid levels (HP:0003112) | 2.87098052 |
47 | Delayed CNS myelination (HP:0002188) | 2.85708406 |
48 | Myocardial infarction (HP:0001658) | 2.84753375 |
49 | Hepatocellular carcinoma (HP:0001402) | 2.83931373 |
50 | Systemic lupus erythematosus (HP:0002725) | 2.71675196 |
51 | Metabolic acidosis (HP:0001942) | 2.67749424 |
52 | Bile duct proliferation (HP:0001408) | 2.65930456 |
53 | Abnormal biliary tract physiology (HP:0012439) | 2.65930456 |
54 | Abnormality of purine metabolism (HP:0004352) | 2.60176484 |
55 | Amyloidosis (HP:0011034) | 2.56835036 |
56 | Glomerulonephritis (HP:0000099) | 2.54063989 |
57 | Hypothermia (HP:0002045) | 2.53177381 |
58 | Acanthocytosis (HP:0001927) | 2.53031216 |
59 | Arthropathy (HP:0003040) | 2.52724428 |
60 | Osteomalacia (HP:0002749) | 2.52322907 |
61 | Gingival bleeding (HP:0000225) | 2.51618645 |
62 | Late onset (HP:0003584) | 2.50289736 |
63 | Vascular calcification (HP:0004934) | 2.48966666 |
64 | Lethargy (HP:0001254) | 2.48278401 |
65 | Mitral stenosis (HP:0001718) | 2.46688594 |
66 | Abnormal gallbladder morphology (HP:0012437) | 2.45835124 |
67 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.45340356 |
68 | Dicarboxylic aciduria (HP:0003215) | 2.43613092 |
69 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.43613092 |
70 | Reduced antithrombin III activity (HP:0001976) | 2.42976788 |
71 | Irritability (HP:0000737) | 2.39406240 |
72 | Hyperventilation (HP:0002883) | 2.39380291 |
73 | Gout (HP:0001997) | 2.38524064 |
74 | Symptomatic seizures (HP:0011145) | 2.34281478 |
75 | Cerebral edema (HP:0002181) | 2.33941051 |
76 | Hyperglycemia (HP:0003074) | 2.33443264 |
77 | Enlarged kidneys (HP:0000105) | 2.31636734 |
78 | Menorrhagia (HP:0000132) | 2.28914320 |
79 | Cholelithiasis (HP:0001081) | 2.27907839 |
80 | Generalized hypopigmentation of hair (HP:0011358) | 2.26736851 |
81 | Abnormality of vitamin metabolism (HP:0100508) | 2.20643806 |
82 | Neonatal onset (HP:0003623) | 2.19166309 |
83 | Pancreatitis (HP:0001733) | 2.18255555 |
84 | Cardiovascular calcification (HP:0011915) | 2.17524552 |
85 | Spastic diplegia (HP:0001264) | 2.16211022 |
86 | Abnormality of alanine metabolism (HP:0010916) | 2.16191465 |
87 | Hyperalaninemia (HP:0003348) | 2.16191465 |
88 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.16191465 |
89 | Thrombophlebitis (HP:0004418) | 2.15882256 |
90 | Hyperphosphaturia (HP:0003109) | 2.15636796 |
91 | Brushfield spots (HP:0001088) | 2.14285046 |
92 | Generalized aminoaciduria (HP:0002909) | 2.12452202 |
93 | Abnormal gallbladder physiology (HP:0012438) | 2.11272405 |
94 | Cholecystitis (HP:0001082) | 2.11272405 |
95 | Sensorimotor neuropathy (HP:0007141) | 2.07422680 |
96 | Opisthotonus (HP:0002179) | 2.07145733 |
97 | Pulmonary embolism (HP:0002204) | 2.04759151 |
98 | Renal cortical cysts (HP:0000803) | 2.03964628 |
99 | Malnutrition (HP:0004395) | 2.03792512 |
100 | Esophageal varix (HP:0002040) | 2.02566621 |
101 | Vomiting (HP:0002013) | 1.99069955 |
102 | Hypophosphatemic rickets (HP:0004912) | 1.98458095 |
103 | Abnormality of the gallbladder (HP:0005264) | 1.97766375 |
104 | Rickets (HP:0002748) | 1.96618862 |
105 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.94758871 |
106 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.94758871 |
107 | Poikilocytosis (HP:0004447) | 1.93051207 |
108 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.92317959 |
109 | Abnormality of iron homeostasis (HP:0011031) | 1.92059949 |
110 | Alkalosis (HP:0001948) | 1.91734911 |
111 | Hemorrhage of the eye (HP:0011885) | 1.90427563 |
112 | Chronic hepatic failure (HP:0100626) | 1.89153993 |
113 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.88016519 |
114 | Abnormality of the renal cortex (HP:0011035) | 1.87281098 |
115 | Hydroxyprolinuria (HP:0003080) | 1.81660534 |
116 | Abnormality of proline metabolism (HP:0010907) | 1.81660534 |
117 | Elevated hepatic transaminases (HP:0002910) | 1.78684763 |
118 | Acute hepatic failure (HP:0006554) | 1.77303725 |
119 | Potter facies (HP:0002009) | 1.77156790 |
120 | Facial shape deformation (HP:0011334) | 1.77156790 |
121 | Proximal tubulopathy (HP:0000114) | 1.76338009 |
122 | Pancreatic cysts (HP:0001737) | 1.75311104 |
123 | Glycosuria (HP:0003076) | 1.74458734 |
124 | Abnormality of urine glucose concentration (HP:0011016) | 1.74458734 |
125 | Joint swelling (HP:0001386) | 1.71861752 |
126 | Blue irides (HP:0000635) | 1.60915480 |
127 | Cerebral palsy (HP:0100021) | 1.58222646 |
128 | Abnormal urine phosphate concentration (HP:0012599) | 1.57555029 |
129 | Congenital stationary night blindness (HP:0007642) | 1.54589629 |
130 | Gangrene (HP:0100758) | 1.50552391 |
131 | Attenuation of retinal blood vessels (HP:0007843) | 1.48086154 |
132 | Neoplasm of the liver (HP:0002896) | 1.47302782 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BCKDK | 6.12947413 |
2 | INSRR | 4.85147458 |
3 | ERN1 | 4.61111183 |
4 | FGFR4 | 4.38195849 |
5 | TAOK3 | 4.22401498 |
6 | SIK1 | 4.01021089 |
7 | ERBB4 | 3.06898426 |
8 | BMPR1B | 2.81592303 |
9 | ADRBK2 | 2.80570225 |
10 | ACVR1B | 2.56080612 |
11 | MAP4K2 | 2.49536211 |
12 | PIK3CG | 2.16095783 |
13 | MAP2K4 | 2.06683877 |
14 | CASK | 2.01986405 |
15 | MAPK15 | 2.01168209 |
16 | NTRK3 | 1.99211079 |
17 | NUAK1 | 1.94693111 |
18 | MST1R | 1.89328654 |
19 | FRK | 1.86596076 |
20 | ZAK | 1.77853729 |
21 | FLT3 | 1.71301381 |
22 | MAPK11 | 1.69679898 |
23 | DAPK2 | 1.63439620 |
24 | MAP3K4 | 1.53696922 |
25 | LATS1 | 1.51881287 |
26 | PTK6 | 1.43284241 |
27 | EPHA3 | 1.41851148 |
28 | CAMKK2 | 1.36677576 |
29 | TYK2 | 1.29367787 |
30 | BRSK2 | 1.23108272 |
31 | JAK2 | 1.18743071 |
32 | PRKAA2 | 1.17429349 |
33 | MAPK13 | 1.16500696 |
34 | EPHB1 | 1.15325230 |
35 | FGFR2 | 1.15161435 |
36 | OXSR1 | 1.14533945 |
37 | EIF2AK3 | 1.14178404 |
38 | PRKCE | 1.12015934 |
39 | ABL2 | 1.10144434 |
40 | TRIB3 | 1.07065161 |
41 | PINK1 | 1.03412023 |
42 | MST4 | 1.02989285 |
43 | MET | 1.01125379 |
44 | IRAK3 | 1.01055460 |
45 | ERBB2 | 1.00359401 |
46 | JAK1 | 0.99747708 |
47 | MAP3K7 | 0.98961621 |
48 | PKN2 | 0.97447257 |
49 | STK39 | 0.97100305 |
50 | GRK1 | 0.96224639 |
51 | MAP3K14 | 0.94685552 |
52 | MAP3K12 | 0.94153514 |
53 | NEK9 | 0.92959883 |
54 | KDR | 0.92891122 |
55 | PDK2 | 0.88042740 |
56 | TLK1 | 0.87439280 |
57 | PKN1 | 0.84586746 |
58 | PRKCZ | 0.81546624 |
59 | MKNK2 | 0.81528989 |
60 | IRAK1 | 0.79475238 |
61 | CAMK2G | 0.79444820 |
62 | PRKACG | 0.79021270 |
63 | ADRBK1 | 0.78954801 |
64 | DYRK1B | 0.78245301 |
65 | CSNK1D | 0.77766850 |
66 | PHKG2 | 0.76355230 |
67 | PHKG1 | 0.76355230 |
68 | TXK | 0.76129932 |
69 | TNK2 | 0.75873920 |
70 | ERBB3 | 0.75611877 |
71 | CAMK1D | 0.75113084 |
72 | MAPK4 | 0.70691204 |
73 | GSK3A | 0.70443443 |
74 | TIE1 | 0.68802388 |
75 | PRKAA1 | 0.68608164 |
76 | STK38L | 0.68542872 |
77 | PTK2 | 0.68282386 |
78 | TBK1 | 0.67859497 |
79 | PRKG1 | 0.67545581 |
80 | MAP3K13 | 0.65657644 |
81 | MAP3K3 | 0.65162959 |
82 | STK3 | 0.64688829 |
83 | MAP3K1 | 0.64419416 |
84 | GRK6 | 0.62034518 |
85 | MAP3K2 | 0.61638398 |
86 | MAPK7 | 0.61332494 |
87 | TRPM7 | 0.61181036 |
88 | BCR | 0.61120501 |
89 | CSNK1A1 | 0.59051331 |
90 | MAP2K7 | 0.58745985 |
91 | CSK | 0.58325826 |
92 | MUSK | 0.57258768 |
93 | MAPKAPK3 | 0.55832394 |
94 | MAPK12 | 0.55114895 |
95 | TEC | 0.55022251 |
96 | FGFR3 | 0.53697287 |
97 | TRIM28 | 0.53359959 |
98 | TNIK | 0.51834125 |
99 | CSNK1G1 | 0.50931359 |
100 | AKT3 | 0.50510656 |
101 | SGK3 | 0.50230382 |
102 | PRKCQ | 0.50123703 |
103 | PDPK1 | 0.48866381 |
104 | SGK2 | 0.48653041 |
105 | SGK223 | 0.47602936 |
106 | SGK494 | 0.47602936 |
107 | PAK3 | 0.47281130 |
108 | MAP2K3 | 0.47092968 |
109 | IGF1R | 0.46175388 |
110 | IRAK2 | 0.45927601 |
111 | PRKCG | 0.44779827 |
112 | CSNK1E | 0.44725660 |
113 | WNK3 | 0.44563480 |
114 | CAMK1G | 0.43716351 |
115 | MAP2K6 | 0.43609390 |
116 | IKBKE | 0.43518538 |
117 | PRKACB | 0.42082577 |
118 | PRKCB | 0.41620969 |
119 | SGK1 | 0.40965296 |
120 | STK11 | 0.40860961 |
121 | PTK2B | 0.40664576 |
122 | MAP2K2 | 0.40373292 |
123 | MAP2K1 | 0.39509100 |
124 | WNK4 | 0.39317045 |
125 | PLK2 | 0.39239983 |
126 | ICK | 0.39129689 |
127 | NLK | 0.38828766 |
128 | DYRK2 | 0.38718119 |
129 | CAMK2A | 0.38290926 |
130 | PIK3CA | 0.38286876 |
131 | CDK6 | 0.37505518 |
132 | MAP3K10 | 0.36968304 |
133 | STK16 | 0.36942581 |
134 | PDK1 | 0.36932097 |
135 | ITK | 0.36640704 |
136 | RET | 0.36481526 |
137 | EPHA4 | 0.36056715 |
138 | PRKCH | 0.33744367 |
139 | MTOR | 0.33008075 |
140 | PRKCA | 0.31810106 |
141 | CHUK | 0.31289803 |
142 | CSNK1G2 | 0.30457365 |
143 | PRKCI | 0.30295983 |
144 | RPS6KA3 | 0.30280799 |
145 | OBSCN | 0.30101057 |
146 | CSNK1A1L | 0.29944089 |
147 | PRKACA | 0.28729508 |
148 | NTRK1 | 0.28027345 |
149 | CSNK1G3 | 0.28007770 |
150 | FER | 0.27208202 |
151 | MAP3K11 | 0.26233885 |
152 | CAMK4 | 0.26059943 |
153 | EGFR | 0.24088141 |
154 | MAP3K6 | 0.23757732 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.52651653 |
2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.54836231 |
3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.24494334 |
4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.19828270 |
5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.02163976 |
6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.98325721 |
7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.74472379 |
8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.59484926 |
9 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.53503200 |
10 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.47362368 |
11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.39520156 |
12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.35517684 |
13 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.17660164 |
14 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.14744140 |
15 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.14618991 |
16 | Peroxisome_Homo sapiens_hsa04146 | 2.07284620 |
17 | Histidine metabolism_Homo sapiens_hsa00340 | 1.95850625 |
18 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.91392254 |
19 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.90684147 |
20 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.87819680 |
21 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.86623925 |
22 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.85279544 |
23 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.81820513 |
24 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.80528602 |
25 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.72591906 |
26 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.70704607 |
27 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.69983016 |
28 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.67764335 |
29 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.67404849 |
30 | Retinol metabolism_Homo sapiens_hsa00830 | 1.62831824 |
31 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.62267680 |
32 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.61221383 |
33 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.60817840 |
34 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.60172842 |
35 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.58760206 |
36 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.57025726 |
37 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.49284706 |
38 | Bile secretion_Homo sapiens_hsa04976 | 1.45754188 |
39 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.36581936 |
40 | ABC transporters_Homo sapiens_hsa02010 | 1.32572241 |
41 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.30092114 |
42 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.29062554 |
43 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.27221185 |
44 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.26951359 |
45 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.25762436 |
46 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.24203119 |
47 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.19054879 |
48 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.09699365 |
49 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.02844127 |
50 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.98446711 |
51 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.97401864 |
52 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.96078310 |
53 | Carbon metabolism_Homo sapiens_hsa01200 | 0.94946920 |
54 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.91823726 |
55 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.86563604 |
56 | Sulfur relay system_Homo sapiens_hsa04122 | 0.84854365 |
57 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.83741302 |
58 | Lysine degradation_Homo sapiens_hsa00310 | 0.81082259 |
59 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.74110327 |
60 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.69075669 |
61 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.63608143 |
62 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.61823115 |
63 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.57309839 |
64 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.54647030 |
65 | Prion diseases_Homo sapiens_hsa05020 | 0.49219778 |
66 | Metabolic pathways_Homo sapiens_hsa01100 | 0.47081563 |
67 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.44551001 |
68 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.41945953 |
69 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.38665010 |
70 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.37144492 |
71 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.34080933 |
72 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.29935867 |
73 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.27447525 |
74 | Insulin resistance_Homo sapiens_hsa04931 | 0.27038250 |
75 | Galactose metabolism_Homo sapiens_hsa00052 | 0.25841465 |
76 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.24887654 |
77 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.21326795 |
78 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.18211850 |
79 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.17897478 |
80 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.16805113 |
81 | Pertussis_Homo sapiens_hsa05133 | 0.15255119 |
82 | Phototransduction_Homo sapiens_hsa04744 | 0.14466409 |
83 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.11271881 |
84 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.11188707 |
85 | Circadian rhythm_Homo sapiens_hsa04710 | 0.10234843 |
86 | Mineral absorption_Homo sapiens_hsa04978 | 0.10090828 |
87 | Protein export_Homo sapiens_hsa03060 | 0.04883949 |
88 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.04089121 |
89 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.02525203 |
90 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.02477363 |
91 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.02247612 |
92 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.2180318 |
93 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1897527 |
94 | Lysosome_Homo sapiens_hsa04142 | -0.1750873 |
95 | Hepatitis C_Homo sapiens_hsa05160 | -0.1744227 |
96 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1449978 |
97 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1422535 |
98 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.1366029 |
99 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1263706 |
100 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1126883 |
101 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1076861 |
102 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0948053 |
103 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.0914306 |
104 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.0890874 |
105 | GABAergic synapse_Homo sapiens_hsa04727 | -0.0714998 |
106 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0628177 |
107 | Oxidative phosphorylation_Homo sapiens_hsa00190 | -0.0510387 |
108 | Nicotine addiction_Homo sapiens_hsa05033 | -0.0383643 |
109 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.0269844 |
110 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0196047 |
111 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.0143141 |
112 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0060444 |
113 | Insulin secretion_Homo sapiens_hsa04911 | -0.0051022 |
114 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.0022856 |